The list, available at Indiana250.com, was compiled by the executives, editors and newsroom staffs at IBJ Media’s three news brands — Indianapolis Business Journal, Inside INdiana Business and Indiana Lawyer — after a monthslong process that included reviewing nominations, researching Indiana organizations and talking with community leaders across the state.
She first gained public notice as a piano soloist with the Indianapolis Symphony Orchestra at age 12. She later endured the tragic deaths of both her father and her husband Frank McKinney Jr. in separate airplane crashes.
His departure comes as his two-year contract with the state expires, but it still increases speculation that he is considering a run for governor in 2024.
If U.S. regulators approve, the drug would be only the second Alzheimer’s treatment convincingly shown to delay the mind-robbing disease—after rival Leqembi. Both drugs pose a serious safety concern—brain swelling and bleeding.
Patty Martin joined BioCrossroads as president and CEO in July 2019. She stepped down from the role in April. She previously worked as chief operating officer of Lilly Diabetes and served as Eli Lilly and Co.’s chief diversity officer and chief alliance officer. She is a member of the Indiana University Foundation and Women’s Philanthropy […]
More than 110,000 Hoosiers suffer from Alzheimer’s disease, which robs people of their memories and abilities to do daily tasks, and is the nation’s sixth-leading cause of death.
The EMA said it would consider whether its review should be extended to other drugs in the same class, known as GLP-1 receptor agonists. Indianapolis-based Eli Lilly and Co.’s Mounjaro is among them.
Officials are eyeing a few commercial and industrial parks they believe could benefit from the model that puts the state in charge of acquiring land and master-planning a site.
In this week’s edition of the IBJ Podcast, reporter John Russell discusses Medicare’s new power to negotiate drug prices and its effects on patients, drug makers and the rest the health care industry. Eli Lilly and Co. would like to see some changes.
David Ricks, CEO of Indianapolis-based drugmaker Eli Lilly and Co., is turning up the volume on his concerns over a new law that would allow Medicare, for the first time, to negotiate drug prices.
The Indianapolis-based drugmaker said it will acquire Sigilon Therapeutics Inc., a six-year-old startup that is developing a technology to help type 1 diabetes patients restore insulin production over sustained periods.
The quasi-public agency behind a mammoth innovation district reassured budget experts Thursday on the risks it’s taking to win competitive business investments and speedily close those deals.
The Indiana Economic Development Corp. received the green light Thursday to spend $122 million to purchase roughly 1,000 acres of land as part of an incentive package to lure a global semiconductor manufacturer to central Indiana.
The plan commission voted unanimously to recommend the rezoning request for Corbett Towns, which include 17 new buildings on 12 acres of undeveloped land.
The LEAP Lebanon Innovation District Planned Unit Development would set development standards for about 6,000 acres of the planned high-tech district in Boone County along Interstate 65 between Indianapolis and Lafayette.
